NeuroSense Therapeutics Ltd —— 现金流量表 (NASDAQ:NRSN) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 1.54 M7.59 M8.45 M-10.13 M-7.67 M — 投资活动产生的现金 17 K3.54 M3.65 M1 000-8 000 — 融资活动产生的现金 11.9 M3.69 M3.9 M10.91 M4.43 M — 自由现金流 1.54 M7.59 M8.45 M-10.14 M-7.68 M —

新闻

Roth/MKM首次覆盖NeuroSense股票,基于ALS药物潜力给予买入评级

Roth/MKM initiates NeuroSense stock with buy on ALS drug potential

Neurosense Therapeutics股价在获得PrimeC澳大利亚专利后上涨

Neurosense Therapeutics stock rises after securing Australian patent for PrimeC

NeuroSense股价上涨，阿尔茨海默病药物显示良好安全性

Neurosense stock rises as Alzheimer’s drug shows favorable safety profile

NRSN stock touches 52-week high at $1.65 amid robust gains

NRSN stock touches 52-week high at $1.52 amid growth optimism

Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights - NeuroSense Therapeutics (NASDAQ:NRSN)

This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday - NeuroSense Therapeutics (NASDAQ:NRSN), Primis Finl (NASDAQ:FRST)